Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control

Fabian Peeks, Thomas A. H. Steunenberg, Foekje de Boer, M. Estela Rubio-Gozalbo, Monique Williams, Rob Burghard, Fabienne Rajas, Maaike H. Oosterveer, David A. Weinstein, Terry G. J. Derks*

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)695-702
Number of pages8
JournalJournal of Inherited Metabolic Disease
Volume40
Issue number5
DOIs
Publication statusPublished - Sep 2017

Keywords

  • CUSUM
  • ESGSDI
  • GSD Ia
  • G6PC
  • Heterogeneity
  • Modifying factors
  • GLUCOSE-6-PHOSPHATASE GENE
  • GLUCOSE-PRODUCTION
  • G6PC GENE
  • MUTATIONS
  • 1A
  • INFANCY

Cite this

Peeks, F., Steunenberg, T. A. H., de Boer, F., Rubio-Gozalbo, M. E., Williams, M., Burghard, R., Rajas, F., Oosterveer, M. H., Weinstein, D. A., & Derks, T. G. J. (2017). Clinical and biochemical heterogeneity between patients with glycogen storage disease type IA: the added value of CUSUM for metabolic control. Journal of Inherited Metabolic Disease, 40(5), 695-702. https://doi.org/10.1007/s10545-017-0039-1